Navigation Links
SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results
Date:3/11/2009

346 General and administrative 1,114,034 1,248,987 4,356,647 4,554,906 Facility Lease termination Gain from lease buyout - - (4,100,000) - Expenses related to relocation and lease buyout - - 116,867 - Total facility lease buyout - - (3,983,133) - Total operating expenses 3,121,645 3,870,027 7,314,341 13,259,948 Loss from operations (2,944,760) (3,647,693) (6,356,021) (11,288,165) Other income (expense) Interest expense (2,917) (4,757) (14,482) (15,724) Interest income 24,308 131,609 229,837 682,010 Other (1,091) - 238 2,941 20,300 126,852 215,593 669,227 Net Loss $(2,924,460) $(3,520,841) $(6,140,428) $(10,618,938) Net loss per share, basic and diluted $(0.07) $(0.09) $(0.15) $(0.28) Shares used in calculation of basic and diluted net loss per share 41,043,770 38,986,882 41,038,797 38,348,560


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
4. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
5. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
6. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
7. China Biopharma, Inc. Announces New Plan of Operation
8. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
9. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
10. Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
11. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--deCODE,genetics,In...ts,"firstday"motionsbytheU.S.BankruptcyCourtforthe...stweekfiledavoluntarypetitionfor,reliefunderChapte...cyCourt. , TheordersissuedbytheBankruptcyCour...ingtheChapter11proceedings.Inparticular,the,compan...
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009)...Newswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHP...day,announcedthatithassubmittedaMAAtotheEuropeanMe...ymereplacementtherapyindevelopment,forthetreatment...icationforvelaglucerasealfathathasbeensubmitted,wi..., Basedonaglobalsupplyshortageofthecurrentlya...
(Date:11/24/2009)...ogram Connects Customers with Partners Validated t...enotek Products , Ottawa,...leading provider of products for biological sample...announced its new global partner program. The prog...k,s partner community and is designed to help part...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... least 45 girls in grades six through nine are exp...e held June 26 to 28 at Madison Area Technical Co...gy employers to encourage young women to consider ...ture hands-on technical activities that introduce ...ing, electronics and electron microscopy, and info...
...e Douglas Stewart Co. has entered into a distrib...on resellers the products of Honestech, Inc. , an...net Protocol (IP) communication and entertainment ...disclosed. , ,Douglas Stewart sells computer produ...a market of 4,500 academic resellers in the United...
...is is part II of a two-part column on the Food and...cused on the recent controversy over Avandia, Glax...efficacy over safety seems to be so deeply integra...e that this has not always been the case. For much...,s primary mandate was to protect the public,s sa...
Other Biology Technology:Reforming FDA: Focus on safety, let market judge efficacy 2Reforming FDA: Focus on safety, let market judge efficacy 3Reforming FDA: Focus on safety, let market judge efficacy 4Reforming FDA: Focus on safety, let market judge efficacy 5Reforming FDA: Focus on safety, let market judge efficacy 6
(Date:11/23/2009)...ON, WI, November 16, 2009 -- A USDOE and USDA stud..., idle cropland, and cropland pasture could be con...nnial grasses, such as switchgrass, from which bio...tock. Economically viable production of a perennia...ies of biomass are removed annually is expected to...
(Date:11/23/2009)...HAM, N.H. University of New Hampshire microbiolog...98,115 to advance understanding of the actinorhiza...o enrich nutrient-poor and contaminated soils. ,...A) awarded Tisa, a professor of molecular, cellula... symbiotic relationship between the bacteria Frank...
(Date:11/23/2009)...versity of Southern California biomedical engineer...lop a new tool to help clinicians distinguish card...hronic problems manageable with drugs and lifestyl... inserted into the arteries feeding the heart, off...) of these blood vessels, often revealing deposits...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Odd Behaviors on Ambien Linked to Brain Circuitry 50681 1Odd Behaviors on Ambien Linked to Brain Circuitry 50681 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3Prostate cancer patients disease free after 5 years likely to be disease free after 10 years 50676 1
...ate University makes an animal heart pump much lik...animal,s body, allowing researchers to expedite th...t surgery. The machine saves researchers time and ...chnologies in a realistic surgical environment, wi...clinical trials. , , Currently, most medical devi...
...predators detect common forms of prey more easily....MC Ecology found that birds will target salamande...ir behavior in response to alterations in the rati...ick, from the University of Tennessee, worked with...of the prevalence of a dorsal stripe among a group...
...l Oceanic and Atmospheric Administration (NOAA) ha...new cooperative institute which will be headquarte...) at Florida Atlantic University in Fort Pierce, F...Carolina Wilmington (UNCW). This is the single lar...U since their inception. The Cooperative Institute...
Other Biology News:'Beating' heart machine expedites research and development of new surgical tools, techniques 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 3
Rabbit Anti-MSY2 / YBOX2 Polyclonal Antibody, Unconjugated from Abcam
Anti-SAPK / JNK Antibody, Unconjugated from Cell Signaling Technology
L-Selenomethionine from Calbiochem
PAP PEN from Invitrogen
Biology Products: